Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigator Clinical Trial for Evaluation of Safety and Tolerability After Transplantation of Fetal Mesencephalic Dopamine Neuronal Precursor Cells in Patients With Parkinson's Disease

NCT01860794 is registered in ClinicalTrials.gov with Bundang CHA Hospital as lead sponsor.

NCT NCT01860794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01860794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigator Clinical Trial for Evaluation of Safety and Tolerability After Transplantation of Fetal Mesencephalic Dopamine Neuronal Precursor Cells in Patients With Parkinson's Disease
Lead sponsor
Bundang CHA Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
May 31, 2013
Completion date
April 30, 2022
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic parkinson disease, primary parkinsonism